Publications by authors named "Beryl L Manning-Geist"

Claim this Profile
E
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
Beryl L Manning-Geist, Madison Miller, Christian Dagher, Sarah H Kim, Marisa Kollmeier

Int J Gynecol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma.
Elizabeth G Thayer, Beryl L Manning-Geist

Gynecol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.
Beryl L Manning-Geist, Mackenzie W Sullivan, Qin Zhou, Alexia Iasonos, Pier Selenica

Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping.
Beryl L Manning-Geist, Jennifer J Mueller

Int J Gynecol Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining the standard of care for low-grade serous ovarian cancer.
Beryl L Manning-Geist, Tal Cantor, Róisín E O'Cearbhaill, Rachel N Grisham

Clin Adv Hematol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial cancer at recurrence: To re-sequence or not to re-sequence.
Katherine Fuh, Beryl L Manning-Geist

Gynecol Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Beryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, Lora H Ellenson, Qin C Zhou

Int J Gynecol Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland

Nat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility-sparing and minimally invasive surgery for early-stage cervical cancer.
Anna Shvygin, Beryl L Manning-Geist, Yukio Sonoda

J Surg Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The highs and lows of serous ovarian cancer.
Rachel N Grisham, Beryl L Manning-Geist, M Herman Chui

Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Tiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, Jessica A Lavery, Carrie Luardo

Gynecol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Beryl L Manning-Geist, Ryan M Kahn, David Nemirovsky, Jeffrey Girshman, Anya Laibangyang

Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
Rachel N Grisham, Beryl L Manning-Geist, M Herman Chui

Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention over screening for ovarian cancer in patients with high-risk germline mutations: Misinterpreting the findings of ALDO.
Beryl L Manning-Geist, Matthew Flint, Kara Long Roche

Gynecol Oncol Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
Ying L Liu, Beryl L Manning-Geist, Andrea Knezevic, Luxue Deng, Maria Bromberg

Gynecol Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Beryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H Kim

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Beryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, Arnaud Da Cruz Paula, Qin C Zhou

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancer.
Beryl L Manning-Geist, Eric Rios-Doria, Emeline M Aviki, Qin Zhou, Alexia Iasonos

Int J Gynecol Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for financial toxicity in patients with gynecologic cancer.
Emeline M Aviki, Beryl L Manning-Geist, Stefania S Sokolowski, Tiffanny Newman, Victoria S Blinder

Am J Obstet Gynecol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Kirsten M Williams, Steven Z Pavletic, Stephanie J Lee, Paul J Martin, Don E Farthing, Beryl L Manning-Geist

Transplant Cell Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study.
Beryl L Manning-Geist, Renee A Cowan, Brooke Schlappe, Kenya Braxton, Yukio Sonoda

Gynecol Oncol Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
Beryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, Alexia Iasonos, Qin Zhou

Gynecol Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of an endometrial cancer patient with Cowden syndrome.
Beryl L Manning-Geist, Sonia Gatius, Ying Liu, Mabel Gil, Arnaud Da Cruz Paula

Gynecol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis.
Beryl L Manning-Geist, Dennis S Chi, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda

Gynecol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quaternary and beyond cytoreduction: An updated and expanded analysis.
Beryl L Manning-Geist, Dennis S Chi, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda

Gynecol Oncol Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis